The Role of Toll-Like Receptors (TLRs) in Infection and Inflammation 2.0

The Role of Toll-Like Receptors (TLRs) in Infection and Inflammation 2.0

  • Ralf Kircheis
  • Oliver Planz
Publisher:ISBN 13: 9783725823444ISBN 10: 3725823448

Paperback & Hardcover deals ―

Amazon IndiaGOFlipkart GOSnapdealGOSapnaOnlineGOJain Book AgencyGOBooks Wagon₹3,477Book ChorGOCrosswordGODC BooksGO

e-book & Audiobook deals ―

Amazon India GOGoogle Play Books GOAudible GO

* Price may vary from time to time.

* GO = We're not able to fetch the price (please check manually visiting the website).

Know about the book -

The Role of Toll-Like Receptors (TLRs) in Infection and Inflammation 2.0 is written by Ralf Kircheis and published by . It's available with International Standard Book Number or ISBN identification 3725823448 (ISBN 10) and 9783725823444 (ISBN 13).

This Special Issue 2.0 continues the conceptional line started in the previous Special Issue, focusing on the involvement of Toll-like receptors (TLRs) and their related signaling pathways in viral infection and inflammation, and emphasizing the therapeutic potential of TLR system modulation for the treatment of acute viral infections and their long-term sequelae and to provide potential targets for treating chronic viral and inflammatory diseases. This Special Issue provides an excellent collection of contemporary reviews and research articles covering a broad variety of topics, ranging from the protective activity of TLRs in viral infections to detrimental disturbances of the host immune system. The most intriguing theme discussed in this second Special Issue is the intercorrelation between acute viral infections and triggered delayed effects, including neuroinflammatory and neurodegenerative long-term sequelae. Notably, new data increasingly show that neurological pathways, such as neurogenesis, neuroinflammation, and cognitive and behavioural aspects, may be influenced by innate, TLR-mediated pathways. In this context, the connection between infection-triggered acute disbalance in TLR activation and resulting neurological sequelae following bacterial (sepsis) or viral infections, including long COVID-associated neurological sequelae, may provide new targets for future treatment options.